<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title10.html">
                                    Title 10
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/10CFR35.html">Part 35
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 35.396  Training for the parenteral administration of unsealed
                            </h3>
                            <p class="depth0">Except as provided in Sec. 35.57, the licensee shall require an  authorized user for the parenteral administration requiring a written  directive, to be a physician who--</p><p class="depth1"><em>(a)</em> Is an authorized user under Sec. 35.390 for uses listed in  Sec. Sec. 35.390(b)(1)(ii)(G)(3) or 35.390(b)(1)(ii)(G)(4), or  equivalent Agreement State requirements; or</p><p class="depth1"><em>(b)</em> Is an authorized user under Sec. Sec. 35.490, 35.690, or  equivalent Agreement State requirements and who meets the requirements  in paragraph (d) of this section; or</p><p class="depth1"><em>(c)</em> Is certified by a medical specialty board whose certification  process has been recognized by the Commission or an Agreement State  under Sec. Sec. 35.490 or 35.690, and who meets the requirements in  paragraph (d) of this section.</p><p class="depth1"><em>(d)</em></p><p class="depth2"><em>(1)</em> Has successfully completed 80 hours of classroom and  laboratory training, applicable to parenteral administrations, for which  a written directive is required, of any beta emitter, or any photon- emitting radionuclide with a photon energy less than 150 keV, and/or  parenteral administration of any other radionuclide for which a written  directive is required. The training must include--</p><p class="depth3"><em>(i)</em> Radiation physics and instrumentation;</p><p class="depth3"><em>(ii)</em> Radiation protection;</p><p class="depth3"><em>(iii)</em> Mathematics pertaining to the use and measurement of  radioactivity;</p><p class="depth3"><em>(iv)</em> Chemistry of byproduct material for medical use; and</p><p class="depth3"><em>(v)</em> Radiation biology; and</p><p class="depth2"><em>(2)</em> Has work experience, under the supervision of an authorized user  who meets the requirements in Sec. Sec. 35.57, 35.390, 35.396, or  equivalent Agreement State requirements, in the parenteral  administration, for which a written directive is required, of any beta  emitter, or any photon-emitting radionuclide with a photon energy less  than 150 keV, and/or parenteral administration of any other radionuclide  for which a written directive is required. A supervising authorized user  who meets the requirements in Sec. 35.390 must have experience in  administering dosages as specified in Sec. Sec. 35.390(b)(1)(ii)(G)(3)  and/or 35.390(b)(1)(ii)(G)(4). The work experience must involve--</p><p class="depth3"><em>(i)</em> Ordering, receiving, and unpacking radioactive materials safely,  and performing the related radiation surveys;</p><p class="depth3"><em>(ii)</em> Performing quality control procedures on instruments used to  determine the activity of dosages, and performing checks for proper  operation of survey meters;</p><p class="depth3"><em>(iii)</em> Calculating, measuring, and safely preparing patient or human  research subject dosages;</p><p class="depth3"><em>(iv)</em> Using administrative controls to prevent a medical event  involving the use of unsealed byproduct material;</p><p class="depth3"><em>(v)</em> Using procedures to contain spilled byproduct material safely,  and using proper decontamination procedures; and</p><p class="depth3"><em>(vi)</em> Administering dosages to patients or human research subjects,  that include at least 3 cases involving the parenteral administration,  for which a written directive is required, of any beta emitter, or any  photon-emitting radionuclide with a photon energy less than 150 keV and/ or at least 3 cases involving the parenteral administration of any other  radionuclide, for which a written directive is required; and</p><p class="depth2"><em>(3)</em> and/or 35.390(b)(1)(ii)(G)(4).  [70 FR 16365, Mar. 30, 2005, as amended at 71 FR 15010, Mar. 27, 2006;  74 FR 33906, July 14, 2009]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
